QuidelOrtho Vitros Fentanyl Test

QuidelOrtho has launched the ARK Fentanyl II Assay. The immunoassay is intended to help hospitals and emergency rooms respond to the demand for enhanced opioid testing and enables on-site fentanyl testing in less than 10 minutes. It runs on the Vitros XT 7600 and 5600 integrated systems and on the Vitros 4600 chemistry system. It is also designated a MicroTip Partnership Assay and is validated for use on MicroTip capable Vitros systems.